Acta Vet. Brno 2021, 90: 191-200

https://doi.org/10.2754/avb202190020191

Determining the expression levels of circulating tumour cell markers in canine mammary tumours

Zeynep Günay Uçmak1, Özlem Timirci Kahraman2, Güldal İnal Gültekin3, Sevgin Değirmencioğlu4, İlhan Yaylım2, Kazım Güvenç1

1Istanbul University-Cerrahpaşa, Faculty of Veterinary Medicine, Department of Obstetrics and Gynaecology, Istanbul, Turkey
2Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Molecular Medicine, Istanbul, Turkey
3Istanbul Okan University, Faculty of Medicine, Department of Physiology, Istanbul, Turkey
4Istanbul Arel University, Faculty of Medicine, Department of Biochemistry, Istanbul, Turkey

Received December 28, 2020
Accepted May 26, 2021

References

1. Abd El-Maqsoud NMR, Abd El-Rehim DM 2014: Clinicopathologic implications of EpCAM and Cox2 expression in breast cancer. Clin Breast Cancer 14: 1-9 <https://doi.org/10.1016/j.clbc.2013.09.006>
2. Alunni-Fabbroni M, Sandri MT 2010: Circulating tumor cells in clinical practice: Methods of detection and possible characterization. Methods 50: 289-297 <https://doi.org/10.1016/j.ymeth.2010.01.027>
3. Bertics PJ, Weber W, Cocher C, Gill GN 1985: Regulation of the epidermal growth factor receptor by phosphorylation. J Cell Biochem 29: 195-208 <https://doi.org/10.1002/jcb.240290304>
4. Bougarn S, Cunha P, Gilbert FB, Meurens F, Rainard P 2011: Validation of candidate reference genes for normalization of quantitative PCR in bovine mammary epithelial cells responding to inflammatory stimuli. J Dairy Sci 94: 2425-2430 <https://doi.org/10.3168/jds.2010-3859>
5. Canadas A, França M, Pereira C, Vilaça R, Vilhena H, Tinoco F, Silva MJ, Ribeiro J, Medeiros R, Oliveira P, Dias-Perreira P, Santos M 2019: Canine mammary tumors: comparison of classification and grading methods in a survival study. Vet Pathol 56: 208-219 <https://doi.org/10.1177/0300985818806968>
6. Carvalho MI1, Guimarães MJ, Pires I, Prada J, Silva-Carvalho R, Lopes C, Queiroga FL 2013: EGFR and microvessel density in canine malignant mammary tumours. Res Vet Sci 95: 1094-1099 <https://doi.org/10.1016/j.rvsc.2013.09.003>
7. da Costa A, Oliveira JT, Gärtner F, Kohn B, Gruber AD, Klopfleisch R 2011: Potential marker for detection of circulating canine mammary tumor cells in the peripheral blood. Vet J 190: 165-168 <https://doi.org/10.1016/j.tvjl.2010.09.027>
8. da Costa A, Kohn B, Gruber AD, Kolpfleisch R 2013: Multiple RT-PCR markers for detection of circulating tumour cells of metastatic canine mammary tumours. Vet J 196: 34-39 <https://doi.org/10.1016/j.tvjl.2012.08.021>
9. Donnay I, Rauis J, Wouters-Ballman P, Devleeschouwer N, Leclerq G, Verstegen JP 1993: Receptors for estrogen, progesterone and epidermal growth factors in normal and tumorous canine mammary tissues. J Reprod Fertil Suppl 47: 501-512
10. Ferreira E, Bertagnolli AC, Cavalcanti MF, Schmitt FC, Cassali GD 2009: The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours. Vet Comp Oncol 7: 230-235 <https://doi.org/10.1111/j.1476-5829.2009.00193.x>
11. Gama A, Gartner F, Alves A, Schmitt F 2009: Immonuhistochemical expression of EGFR in canine mammary tissues. Res Vet Sci 87: 432-437 <https://doi.org/10.1016/j.rvsc.2009.04.016>
12. Gao S, Sun Y, Liu X, Zhang D, Yang X 2017: EpCAM and COX2 expression are positively correlated in human breast cancer. Mol Med Rep 15: 3755-3760 <https://doi.org/10.3892/mmr.2017.6447>
13. Gires O, Pan M, Schinke H, Canis M, Baeuerle PA 2020: Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years? Cancer Metastasis Rev 39: 969-987 <https://doi.org/10.1007/s10555-020-09898-3>
14. Goldschmidt M, Pena L, Rasotto R, Zappulli V 2011: Classification and grading of canine mammary tumors. Vet Pathol 48: 117-131 <https://doi.org/10.1177/0300985810393258>
15. Guimarães MJ, Carvalho MI, Pires I, Prada J, Gonzales Gil A, Lopes C, Queiroga FL 2014: Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours. J Comp Pathol 150: 27-34 <https://doi.org/10.1016/j.jcpa.2013.07.005>
16. Gundim LF, de Araùjo CP, Blanca WT, Guimaraes EC, Medeiros AA 2016: Clinical staging in bitches with mammary tumors: Influence of type and histological grade. Can J Vet Res 80: 318-322
17. Hammer SC, Becker A, Rateitschak K, Mohr A, Lüder Ripoli F, Hennecke S, Junginger J, Hewicker-Trautwein M, Brenig B, Ngezahayo A, Nolte I, Murua Escobar H 2016: Longitudinal claudin gene expression analyses in canine mammary tissues and thereof derived primary cultures and cell Lines. Int J Mol Sci 17: 1655 <https://doi.org/10.3390/ijms17101655>
18. Hvid H, Ekstrom CT, Veinberg S, Oleksiewicz MB, Klopfleisch R 2011: Identification of stable and oestrus cycle-independent housekeeping genes in the rat mammary gland and other tissues. Vet J 190: 103-108 <https://doi.org/10.1016/j.tvjl.2010.09.002>
19. Hu MS, Maan ZN, Leavitt T, Hong WX, Rennert RC, Marshall CD, Borrelli MR, Zhu TN, Esquivel M, Zimmermann A, McArdle A, Chung MT, Foster DS, Jones RE, Gurtner GC, Giaccia AJ, Lorenz HP, Weissman IL, Longaker MT 2021: Wounds inhibit tumor growth in vivo. Ann Surg 273: 173-180 <https://doi.org/10.1097/SLA.0000000000003255>
20. Jakab C, Halász J, Szász AM, Kiss A, Schaff Z, Rusvai M, Gálfi P, Kulka J 2008: Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours. J Comp Pathol 139: 238-245 <https://doi.org/10.1016/j.jcpa.2008.08.001>
21. Kaszak I, Ruszczak A, Kanafa S, Kacprzak K, Krol M, Jurka P 2018: Current biomarkers of canine mammary tumors. Acta Vet Scand 60: 66 <https://doi.org/10.1186/s13028-018-0417-1>
22. Kennedy KC, Qurollo BA, Rose BJ, Thamm DH 2011: Epidermal growth factor enhance the malignant phenotype in canine mammary carcinoma cell lines. Vet Comp Oncol 9: 196-206 <https://doi.org/10.1111/j.1476-5829.2010.00248.x>
23. Kirsan I, Ucmak M, Apaydin S 2005: Clinical evaluation of the complications found in bitches after total bilateral mastectomy operations. Med Weter 61: 507-509
24. Koltai Z, Szabó B, Jakus J, Vajdovich P 2018: Tyrosine kinase expression analyses in canine mammary gland tumours - a pilot study. Acta Vet Hung 66: 294-308 <https://doi.org/10.1556/004.2018.027>
25. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi O, Sukumar S 2003: Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22: 2021-2033 <https://doi.org/10.1038/sj.onc.1206199>
26. Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C 2011: Detection of EPCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Acta Oncol 50: 700-710 <https://doi.org/10.3109/0284186X.2010.549151>
27. Lee CH, Lee SJ, Choi SH, Ahn SH, Son BH, Lee JW, Yu JH, Kwon NJ, Lee WC, Yang KS, Lee DH, Han DY, Choi MS, Park P, Lee HK, Kim MS, Lee J, Jeon BH 2018: Cancer panel analysis of circulating tumor cells in patients with breast cancer. Oncol Lett 16: 612-618
28. Li X, Fu L, Liu M, Fu M 2016: Expression of epithelial cell adhesion molecule and molecular subtypes and prognosis of breast cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban 41: 258-263
29. Nübel T, Preobraschenski J, Tuncay H, Weiss T, Kuhn S, Ladwein M, Langbein L, Zöller M 2009: Claudin-7 regulates EpCAM-mediated functions in tumor progression. Mol Cancer Res 7: 285-299 <https://doi.org/10.1158/1541-7786.MCR-08-0200>
30. Oshima T, Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T, Makino H, Yamagishi S, Nagano Y, Fujii S, Shiozawa M, Akaike M, Wada N, Rino Y, Masuda M, Tanaka K, Imada T 2008: Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer. Oncol Rep 19: 953-959
31. Owen LN 1980: Clinical stages (TNM) of canine mammary tumors. In: Owen LD (Ed.): TNM Classification of Tumors in Domestic Animals. World Health Organization, Switzerland, pp. 16-18
32. Pavšič M, Gunčar G, Djinović-Carugo K, Lenarčič B 2014: Crystal structure and its bearing towards an understanding of key biological functions of EpCAM. Nat Commun 5: 4764 <https://doi.org/10.1038/ncomms5764>
33. Queiroga FL, Perez-Alenza MD, Gonzalez-Gil A, Silvan G, Pena L, Illera JC 2017: Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications. Vet Comp Oncol 15: 383-390 <https://doi.org/10.1111/vco.12174>
34. Ring A, Mineyev N, Zhu W, Park E, Lomas C, Punj V, Yu M, Barrak D, Forte V, Porras T, Tripathy D, Lang JE 2015: EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low. Oncotarget 6: 44623-4434 <https://doi.org/10.18632/oncotarget.5977>
35. Sauer T, Pedersen MK, Ebeltoft K, Naess O 2005: Reduced expression of claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 16: 193-198 <https://doi.org/10.1111/j.1365-2303.2005.00257.x>
36. Sleeckx N, Rooster H, Veldhuis Kroeze EJB, Van Ginneken C, Van Brantegem L 2011: Canine mammary tumours, an overview. Reprod Domest Anim 46: 1112-1131 <https://doi.org/10.1111/j.1439-0531.2011.01816.x>
37. Soysal SD, Muenst S, Barbie T, Fleming T, Gao F, Spizzo G, Oertli D, Viehl CT, Obermann EC, Gillanders WE 2013: EPCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like and HER2 intrinsic subtypes of breast cancer. Br J Cancer 108: 1480-1487 <https://doi.org/10.1038/bjc.2013.80>
38. St-Arnaud R, Chabot JG, Pelletier G, Labrie F, Walker P 1984: Epidermal growth factor: structure, location, phosphorylation and regulation of its receptor. Biochimie 66: 515-530 <https://doi.org/10.1016/0300-9084(84)90146-9>
39. Tandon AK, Clark GM, Chamness GC, McGuire WL 1990: Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer. Cancer Res 50: 3317-3321
40. Tang Y, Zhu L, Li Y, Ji J, Li J, Yuan F, Wang D, Chen W, Huang O, Chen X, Wu J, Shen K, Loo WTY, Chow LWC 2012: Overexpression of epitethelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotheraphy in patients with triple-negative breast cancer. J Transl Med 10: 1-7 <https://doi.org/10.1186/1479-5876-10-S1-S4>
41. Thamm DH, Hayes DF, Meuten T, Laver T, Thomas DG 2016: Epithelial cell adhesion molecule expression in canine tumours. J Comp Pathol 155: 299-304 <https://doi.org/10.1016/j.jcpa.2016.07.010>
42. Wu CJ, Mannan P, Lu M, Udey MC 2013: Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions. J Biol Chem 288: 12253-12268 <https://doi.org/10.1074/jbc.M113.457499>
43. Zhang S, Tiecheng W, Peng X, Liu J, Liu F, Wu S, Liu S, Dong Y, Xie S, Ma S 2017: Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients. Cancer Manag Res 9: 691-700 <https://doi.org/10.2147/CMAR.S149801>
front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Indexed in DOAJ

Archive